1. Home
  2. SEMR vs SUPN Comparison

SEMR vs SUPN Comparison

Compare SEMR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEMR
  • SUPN
  • Stock Information
  • Founded
  • SEMR 2008
  • SUPN 2005
  • Country
  • SEMR United States
  • SUPN United States
  • Employees
  • SEMR N/A
  • SUPN N/A
  • Industry
  • SEMR EDP Services
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEMR Technology
  • SUPN Health Care
  • Exchange
  • SEMR Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • SEMR 1.9B
  • SUPN 2.0B
  • IPO Year
  • SEMR 2021
  • SUPN 2012
  • Fundamental
  • Price
  • SEMR $12.20
  • SUPN $35.43
  • Analyst Decision
  • SEMR Buy
  • SUPN Hold
  • Analyst Count
  • SEMR 7
  • SUPN 1
  • Target Price
  • SEMR $16.14
  • SUPN $36.00
  • AVG Volume (30 Days)
  • SEMR 525.2K
  • SUPN 348.6K
  • Earning Date
  • SEMR 11-07-2024
  • SUPN 11-04-2024
  • Dividend Yield
  • SEMR N/A
  • SUPN N/A
  • EPS Growth
  • SEMR N/A
  • SUPN 130.79
  • EPS
  • SEMR 0.08
  • SUPN 1.07
  • Revenue
  • SEMR $357,567,000.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • SEMR $24.50
  • SUPN $7.82
  • Revenue Next Year
  • SEMR $20.36
  • SUPN N/A
  • P/E Ratio
  • SEMR $158.54
  • SUPN $33.12
  • Revenue Growth
  • SEMR 22.01
  • SUPN 6.79
  • 52 Week Low
  • SEMR $9.64
  • SUPN $25.53
  • 52 Week High
  • SEMR $16.42
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • SEMR 32.93
  • SUPN 43.56
  • Support Level
  • SEMR $12.21
  • SUPN $35.68
  • Resistance Level
  • SEMR $14.30
  • SUPN $37.35
  • Average True Range (ATR)
  • SEMR 0.50
  • SUPN 1.10
  • MACD
  • SEMR -0.20
  • SUPN -0.24
  • Stochastic Oscillator
  • SEMR 13.36
  • SUPN 32.41

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: